PSA Kinetics Is Not A Sufficient Indication For The Treatment Of Prostate Cancer

PSA Kinetics Is Not A Sufficient Indication For The Treatment Of Prostate Cancer.
A knowledge that urologists had hoped would transform it reasonable to distinguish men with prostate cancer who need treatment from those who would only need watchful waiting didn't accomplish well, researchers report. The technique, called PSA kinetics, measures changes in the figure at which the prostate gland produces a protein called prostate-specific antigen helped.top. A significant burgeon in PSA kinetics, measured by the time during which PSA production doubles or increases at a high-speed rate, is supposed to indicate the need for treatment, by radiation therapy or surgery.

PSA kinetics has prolonged been used to measure the effectiveness of treatment top. A number of cancer centers have started to use it as a workable method of distinguishing aggressive cancers that require treatment from those that are so slow-growing that they can safely be left alone.

Recent studies indicating that many men with slow-growing prostate cancers subject oneself to unnecessary treatment have given imperativeness to the search for such a tool, especially considering that side effects of treatment can include incontinence and impotence. But the mull over indicates that "PSA kinetics doesn't seem to be enough to show you who you should follow and who you should treat," said Dr Ashley E Ross, a urology abiding at the Johns Hopkins University Brady Urological Institute, and standard author of a report on the technique published online May 3 in the Journal of Clinical Oncology.

The discharge describes the results of PSA kinetics measurements of 290 men with low-grade prostate cancer - the big-hearted that often doesn't require treatment - for an average of 2,9 years. The results of PSA tests were compared with biopsies - fabric samples - that cautious the progression of the cancers.

The trial is part of a study, under supervision of Dr H Ballentine Carter, superintendent of the division of adult urology at the Brady Urological Institute, that began in 1994. Men in the whack had PSA tests every six months and biopsies every year.